14
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Applying the Popular Opinion Leader Intervention for HIV to COVID-19

      research-article
      AIDS and Behavior
      Springer US

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The 2019 novel coronavirus disease (COVID-19) pandemic has demanded an immediate public health response and community-wide adoption of various behavior change strategies. Public health guidelines and recommendations emerged rapidly and have been modified as the pandemic has shifted. As a result, the public has received inconsistent and occasionally inaccurate information, contributing to misinformation and mistrust of public health recommendations [1]. As Jaiswal et al. have recently noted, the spread of medical mistrust and public health misinformation evident in the current COVID-19 pandemic mirrors long-standing challenges in the HIV epidemic [1]. Accordingly, we can take lessons learned from the HIV epidemic about the spread of public health information and its effects on behavior change apply them to the current pandemic. This Note focuses on social networks and the popular opinion leader model, which may be key in disseminating trusted information about COVID-19 in a rapidly changing public health landscape. Social networks are critical in norm formation and behavioral adoption, and have been shown to impact a variety of public health outcomes, including HIV [2–5]. Since the early years of the HIV epidemic, social network interventions have been used to disseminate trusted information to vulnerable communities [6, 7]. Based on diffusion of innovation theory [8], the Popular Opinion Leader (POL) model posits that behavior change is achieved when new risk-reducing methods for HIV are disseminated by social network opinion leaders through their personal networks. As outlined by Kelly, the POL model identifies socially influential members of a population who have sufficient large social networks. These individuals are then trained in how to effectively communicate risk reduction strategies to their peers during everyday conversations and are able to establish momentum as a community social movement [9, 10]. Designed as a community-level intervention targeting gay and bisexual men, this intervention has demonstrated effectiveness at increasing HIV prevention knowledge and behaviors, facilitating PEP interest and uptake, and reducing HIV-related stigma [10–14]. Social network and POL interventions may be particularly applicable to other public health crises, including COVID-19. Similar to HIV, the early COVID-19 pandemic has been characterized by stigma, misinformation, and medical mistrust [1, 15]. Perceptions of blame, personal responsibility, and infection risk contribute to detrimental health outcomes and quality of life among affected individuals and those perceived to be at-risk. Furthermore, stereotypes and judgments about disproportionately affected groups can generate stigma and inform the public response to disease [16]. For example, asymptomatic individuals who are infected with coronavirus have been referred to as “carriers” [17] reminiscent of the narrative surrounding “HIV carriers” evident in the early years of the disease. This type of terminology can contribute to fear, public perceptions about who might be a “carrier,” and stigma about certain groups of people. The COVID-19 outbreak began in Wuhan, China, which sparked early reports of racism and xenophobia toward Asian Americans in the United States (US). Since mid-March 2020, there have been over 1,700 reports of racism and xenophobia toward Asian Americans, including microaggressions and violent attacks [18]. In the months following, the concentration of diagnoses and deaths related to COVID-19 in African American and Latinx communities illuminated long-standing structural racism in the US [19, 20], and led to blame of Black individuals for high mortality rates within their communities [20]. Emerging data show stark racial disparities in COVID-19. For example, one analysis found that counties that had majority-Black -populations had COVID-19 infection rates three times that of majority-white counties [21]. Additionally, a Centers for Disease Control and Prevention analysis found that of nearly 1500 hospitalizations due to COVID-19, nearly one-third were among Black people, despite accounting for 18% of the population in the areas studied [22]. Similar to the disparities evident in HIV/AIDS, the stark racial disparities in COVID-19 are rooted in systemic and contemporary racism and health and economic inequity that has made Black Americans more vulnerable to the virus. Stigma resulting from xenophobia or racism can limit access to accurate public health information, alienate communities from needed prevention and treatment resources, and further contribute to disparities in disease outcomes [23–25]. Similarly, misinformation about COVID-19 has emerged as a result of medical mistrust, which has also plagued the public health response to the HIV epidemic [13, 26, 27]. Medical mistrust is a primary driver of racial and ethnic health inequities [28] and can stem from historical and persistent racism, oppression, and disadvantage faced by people of color in the United States. Similar to what has been documented in the HIV literature [25–27, 29], medical mistrust may contribute to lack of COVID-19 testing, delayed access to needed medical care, and misinformation about COVID-19. Yet, engaging trusted community leaders and social influencers to disseminate accurate public health information may help overcome these challenges to address inequities reduce COVID-19 stigma, and strengthen norms that contribute to sustained behavior change (e.g. social distancing, mask wearing, hand washing). Trusted influencers from within one’s community who endorse COVID-19 prevention steps can add trust and credibility to public health messaging, particularly if there is mistrust of official authorities (e.g. medical system, public health departments, and state and local government). Our prior research has shown that peer endorsements and health advice from friends and members of one’s social network are effective at facilitating population-level HIV behavior change [13, 30]. As we have demonstrated [13, 30], most community members want to help friends in a time of crises. Endorsements by popular opinion leaders within their social networks convey that health protective steps are possible, can reduce stigma, strengthen peer norms concerning the benefits of taking protective measures, and increase solidarity [5, 13, 30]. In racial and ethnic minority communities where medical mistrust is high [31, 32], advice from personally known and trusted individuals establishes information credibility and can help overcome mistrust and misinformation [33]. Applying the POL Model to COVID-19 Given our experience implementing the POL model with populations at risk for HIV, we are currently applying this model to communities being affected by COVID-19. As has been documented in many parts of the country, there are significant racial and ethnic disparities in COVID-19 in Milwaukee [34, 35]. Although 6.7% of Wisconsin’s residents are Black, they have comprised 21% of confirmed COVID-cases and 29% of COVID-related deaths. Additionally, over 30% of COVID cases are among individuals who identify as Hispanic or Latino, although they represent just 6.9% of the state’s population [35]. With funding from the Advancing a Healthier Wisconsin Endowment, our project, 1000 Hometown Heroes, aims to engage 1000 local “heroes” in Milwaukee from predominantly African American and Latinx communities in an effort to address the racial and ethnic disparities in COVID-19. These ‘heroes’ are social influencers and leaders on various social media platforms who will share accurate, culturally relevant, tailored information about COVID-19 with their networks. We are recruiting POL who see themselves as change agents, want to help protect the health and psychosocial well-being of others in their communities, and are willing to spread the word about COVID-19 prevention and reduce disease stigma. Additionally, we are providing influencers information to connect community members to needed services, provide strategies to cope with stress, anxiety, and social distancing, and provide accurate, up-to-date information about the status of COVID-19 in the Milwaukee area. Aligned with social distancing guidelines for COVID-19 prevention, we are using online social networks as an efficient and effective way to disseminate accurate information and influence community norms and behaviors [36]. The POL model has been successfully adapted to online networks, allowing peer influencers to reach a large number of people in a cost-effective approach [37]. In many ways, this approach is a modernization of efforts implemented during the 1918 flu pandemic. Postal workers, Boy Scouts, and teachers, as trusted community members, were asked to volunteer for health education campaigns and go door-to-door to educate families about public health practices [38]. With the advent of numerous social media platforms, we now have an opportunity for more efficient information spread from a larger segment of the population. Over the next six months, we will be evaluating the program’s reach and effectiveness, which may provide some early indication about how to quickly disseminate accurate, trusted information during public health crises, particularly to communities hardest hit by an epidemic. Adapting the popular opinion model, which has demonstrated significant success in HIV prevention, to COVID-19 is one example of how HIV prevention and intervention researchers can take lessons learned in HIV and apply them to current and future pandemics. While much of our current HIV research is on hold indefinitely, we have an opportunity to pivot and use what we have learned from nearly four decades of HIV research to assist in addressing the impact of COVID-19. We have a wealth of knowledge about infectious disease, stigma, sustained behavior modification, and social and structural facilitators of health disparities that should be adapted and shared to address other emerging infectious diseases.

          Related collections

          Most cited references25

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020

          Since SARS-CoV-2, the novel coronavirus that causes coronavirus disease 2019 (COVID-19), was first detected in December 2019 ( 1 ), approximately 1.3 million cases have been reported worldwide ( 2 ), including approximately 330,000 in the United States ( 3 ). To conduct population-based surveillance for laboratory-confirmed COVID-19–associated hospitalizations in the United States, the COVID-19–Associated Hospitalization Surveillance Network (COVID-NET) was created using the existing infrastructure of the Influenza Hospitalization Surveillance Network (FluSurv-NET) ( 4 ) and the Respiratory Syncytial Virus Hospitalization Surveillance Network (RSV-NET). This report presents age-stratified COVID-19–associated hospitalization rates for patients admitted during March 1–28, 2020, and clinical data on patients admitted during March 1–30, 2020, the first month of U.S. surveillance. Among 1,482 patients hospitalized with COVID-19, 74.5% were aged ≥50 years, and 54.4% were male. The hospitalization rate among patients identified through COVID-NET during this 4-week period was 4.6 per 100,000 population. Rates were highest (13.8) among adults aged ≥65 years. Among 178 (12%) adult patients with data on underlying conditions as of March 30, 2020, 89.3% had one or more underlying conditions; the most common were hypertension (49.7%), obesity (48.3%), chronic lung disease (34.6%), diabetes mellitus (28.3%), and cardiovascular disease (27.8%). These findings suggest that older adults have elevated rates of COVID-19–associated hospitalization and the majority of persons hospitalized with COVID-19 have underlying medical conditions. These findings underscore the importance of preventive measures (e.g., social distancing, respiratory hygiene, and wearing face coverings in public settings where social distancing measures are difficult to maintain) † to protect older adults and persons with underlying medical conditions, as well as the general public. In addition, older adults and persons with serious underlying medical conditions should avoid contact with persons who are ill and immediately contact their health care provider(s) if they have symptoms consistent with COVID-19 (https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html) ( 5 ). Ongoing monitoring of hospitalization rates, clinical characteristics, and outcomes of hospitalized patients will be important to better understand the evolving epidemiology of COVID-19 in the United States and the clinical spectrum of disease, and to help guide planning and prioritization of health care system resources. COVID-NET conducts population-based surveillance for laboratory-confirmed COVID-19–associated hospitalizations among persons of all ages in 99 counties in 14 states (California, Colorado, Connecticut, Georgia, Iowa, Maryland, Michigan, Minnesota, New Mexico, New York, Ohio, Oregon, Tennessee, and Utah), distributed across all 10 U.S Department of Health and Human Services regions. § The catchment area represents approximately 10% of the U.S. population. Patients must be residents of a designated COVID-NET catchment area and hospitalized within 14 days of a positive SARS-CoV-2 test to meet the surveillance case definition. Testing is requested at the discretion of treating health care providers. Laboratory-confirmed SARS-CoV-2 is defined as a positive result by any test that has received Emergency Use Authorization for SARS-CoV-2 testing. ¶ COVID-NET surveillance officers in each state identify cases through active review of notifiable disease and laboratory databases and hospital admission and infection control practitioner logs. Weekly age-stratified hospitalization rates are estimated using the number of catchment area residents hospitalized with laboratory-confirmed COVID-19 as the numerator and National Center for Health Statistics vintage 2018 bridged-race postcensal population estimates for the denominator.** As of April 3, 2020, COVID-NET hospitalization rates are being published each week at https://gis.cdc.gov/grasp/covidnet/COVID19_3.html. For each case, trained surveillance officers conduct medical chart abstractions using a standard case report form to collect data on patient characteristics, underlying medical conditions, clinical course, and outcomes. Chart reviews are finalized once patients have a discharge disposition. COVID-NET surveillance was initiated on March 23, 2020, with retrospective case identification of patients admitted during March 1–22, 2020, and prospective case identification during March 23–30, 2020. Clinical data on underlying conditions and symptoms at admission are presented through March 30; hospitalization rates are updated weekly and, therefore, are presented through March 28 (epidemiologic week 13). The COVID-19–associated hospitalization rate among patients identified through COVID-NET for the 4-week period ending March 28, 2020, was 4.6 per 100,000 population (Figure 1). Hospitalization rates increased with age, with a rate of 0.3 in persons aged 0–4 years, 0.1 in those aged 5–17 years, 2.5 in those aged 18–49 years, 7.4 in those aged 50–64 years, and 13.8 in those aged ≥65 years. Rates were highest among persons aged ≥65 years, ranging from 12.2 in those aged 65–74 years to 17.2 in those aged ≥85 years. More than half (805; 54.4%) of hospitalizations occurred among men; COVID-19-associated hospitalization rates were higher among males than among females (5.1 versus 4.1 per 100,000 population). Among the 1,482 laboratory-confirmed COVID-19–associated hospitalizations reported through COVID-NET, six (0.4%) each were patients aged 0–4 years and 5–17 years, 366 (24.7%) were aged 18–49 years, 461 (31.1%) were aged 50–64 years, and 643 (43.4%) were aged ≥65 years. Among patients with race/ethnicity data (580), 261 (45.0%) were non-Hispanic white (white), 192 (33.1%) were non-Hispanic black (black), 47 (8.1%) were Hispanic, 32 (5.5%) were Asian, two (0.3%) were American Indian/Alaskan Native, and 46 (7.9%) were of other or unknown race. Rates varied widely by COVID-NET surveillance site (Figure 2). FIGURE 1 Laboratory-confirmed coronavirus disease 2019 (COVID-19)–associated hospitalization rates,* by age group — COVID-NET, 14 states, † March 1–28, 2020 Abbreviation: COVID-NET = Coronavirus Disease 2019–Associated Hospitalization Surveillance Network. * Number of patients hospitalized with COVID-19 per 100,000 population. † Counties included in COVID-NET surveillance: California (Alameda, Contra Costa, and San Francisco counties); Colorado (Adams, Arapahoe, Denver, Douglas, and Jefferson counties); Connecticut (New Haven and Middlesex counties); Georgia (Clayton, Cobb, DeKalb, Douglas, Fulton, Gwinnett, Newton, and Rockdale counties); Iowa (one county represented); Maryland (Allegany, Anne Arundel, Baltimore, Baltimore City, Calvert, Caroline, Carroll, Cecil, Charles, Dorchester, Frederick, Garrett, Harford, Howard, Kent, Montgomery, Prince George’s, Queen Anne’s, St. Mary’s, Somerset, Talbot, Washington, Wicomico, and Worcester counties); Michigan (Clinton, Eaton, Genesee, Ingham, and Washtenaw counties); Minnesota (Anoka, Carver, Dakota, Hennepin, Ramsey, Scott, and Washington counties); New Mexico (Bernalillo, Chaves, Dona Ana, Grant, Luna, San Juan, and Santa Fe counties); New York (Albany, Columbia, Genesee, Greene, Livingston, Monroe, Montgomery, Ontario, Orleans, Rensselaer, Saratoga, Schenectady, Schoharie, Wayne, and Yates counties); Ohio (Delaware, Fairfield, Franklin, Hocking, Licking, Madison, Morrow, Perry, Pickaway and Union counties); Oregon (Clackamas, Multnomah, and Washington counties); Tennessee (Cheatham, Davidson, Dickson, Robertson, Rutherford, Sumner, Williamson, and Wilson counties); and Utah (Salt Lake County). The figure is a bar chart showing laboratory-confirmed COVID-19–associated hospitalization rates, by age group, in 14 states during March 1–28, 2020 according to the Coronavirus Disease 2019–Associated Hospitalization Surveillance Network. FIGURE 2 Laboratory-confirmed coronavirus disease 2019 (COVID-19)–associated hospitalization rates,* by surveillance site † — COVID-NET, 14 states, March 1–28, 2020 Abbreviation: COVID-NET = Coronavirus Disease 2019–Associated Hospitalization Surveillance Network. * Number of patients hospitalized with COVID-19 per 100,000 population. † Counties included in COVID-NET surveillance: California (Alameda, Contra Costa, and San Francisco counties); Colorado (Adams, Arapahoe, Denver, Douglas, and Jefferson counties); Connecticut (New Haven and Middlesex counties); Georgia (Clayton, Cobb, DeKalb, Douglas, Fulton, Gwinnett, Newton, and Rockdale counties); Iowa (one county represented); Maryland (Allegany, Anne Arundel, Baltimore, Baltimore City, Calvert, Caroline, Carroll, Cecil, Charles, Dorchester, Frederick, Garrett, Harford, Howard, Kent, Montgomery, Prince George’s, Queen Anne’s, St. Mary’s, Somerset, Talbot, Washington, Wicomico, and Worcester counties); Michigan (Clinton, Eaton, Genesee, Ingham, and Washtenaw counties); Minnesota (Anoka, Carver, Dakota, Hennepin, Ramsey, Scott, and Washington counties); New Mexico (Bernalillo, Chaves, Dona Ana, Grant, Luna, San Juan, and Santa Fe counties); New York (Albany, Columbia, Genesee, Greene, Livingston, Monroe, Montgomery, Ontario, Orleans, Rensselaer, Saratoga, Schenectady, Schoharie, Wayne, and Yates counties); Ohio (Delaware, Fairfield, Franklin, Hocking, Licking, Madison, Morrow, Perry, Pickaway and Union counties); Oregon (Clackamas, Multnomah, and Washington counties); Tennessee (Cheatham, Davidson, Dickson, Robertson, Rutherford, Sumner, Williamson, and Wilson counties); and Utah (Salt Lake County). The figure is a bar chart showing laboratory-confirmed COVID-19–associated hospitalization rates, by surveillance site, in 14 states during March 1–28, 2020 according to the Coronavirus Disease 2019–Associated Hospitalization Surveillance Network. During March 1–30, underlying medical conditions and symptoms at admission were reported through COVID-NET for approximately 180 (12.1%) hospitalized adults (Table); 89.3% had one or more underlying conditions. The most commonly reported were hypertension (49.7%), obesity (48.3%), chronic lung disease (34.6%), diabetes mellitus (28.3%), and cardiovascular disease (27.8%). Among patients aged 18–49 years, obesity was the most prevalent underlying condition, followed by chronic lung disease (primarily asthma) and diabetes mellitus. Among patients aged 50–64 years, obesity was most prevalent, followed by hypertension and diabetes mellitus; and among those aged ≥65 years, hypertension was most prevalent, followed by cardiovascular disease and diabetes mellitus. Among 33 females aged 15–49 years hospitalized with COVID-19, three (9.1%) were pregnant. Among 167 patients with available data, the median interval from symptom onset to admission was 7 days (interquartile range [IQR] = 3–9 days). The most common signs and symptoms at admission included cough (86.1%), fever or chills (85.0%), and shortness of breath (80.0%). Gastrointestinal symptoms were also common; 26.7% had diarrhea, and 24.4% had nausea or vomiting. TABLE Underlying conditions and symptoms among adults aged ≥18 years with coronavirus disease 2019 (COVID-19)–associated hospitalizations — COVID-NET, 14 states,* March 1–30, 2020† Underlying condition Age group (yrs), no./total no. (%) Overall 18–49 50–64 ≥65 years Any underlying condition 159/178 (89.3) 41/48 (85.4) 51/59 (86.4) 67/71 (94.4) Hypertension 79/159 (49.7) 7/40 (17.5) 27/57 (47.4) 45/62 (72.6) Obesity§ 73/151 (48.3) 23/39 (59.0) 25/51 (49.0) 25/61 (41.0) Chronic metabolic disease¶ 60/166 (36.1) 10/46 (21.7) 21/56 (37.5) 29/64 (45.3)    Diabetes mellitus 47/166 (28.3) 9/46 (19.6) 18/56 (32.1) 20/64 (31.3) Chronic lung disease 55/159 (34.6) 16/44 (36.4) 15/53 (28.3) 24/62 (38.7)    Asthma 27/159 (17.0) 12/44 (27.3) 7/53 (13.2) 8/62 (12.9)    Chronic obstructive pulmonary disease 17/159 (10.7) 0/44 (0.0) 3/53 (5.7) 14/62 (22.6) Cardiovascular disease** 45/162 (27.8) 2/43 (4.7) 11/56 (19.6) 32/63 (50.8)    Coronary artery disease 23/162 (14.2) 0/43 (0.0) 7/56 (12.5) 16/63 (25.4)    Congestive heart failure 11/162 (6.8) 2/43 (4.7) 3/56 (5.4) 6/63 (9.5) Neurologic disease 22/157 (14.0) 4/42 (9.5) 4/55 (7.3) 14/60 (23.3) Renal disease 20/153 (13.1) 3/41 (7.3) 2/53 (3.8) 15/59 (25.4) Immunosuppressive condition 15/156 (9.6) 5/43 (11.6) 4/54 (7.4) 6/59 (10.2) Gastrointestinal/Liver disease 10/152 (6.6) 4/42 (9.5) 0/54 (0.0) 6/56 (10.7) Blood disorder 9/156 (5.8) 1/43 (2.3) 1/55 (1.8) 7/58 (12.1) Rheumatologic/Autoimmune disease 3/154 (1.9) 1/42 (2.4) 0/54 (0.0) 2/58 (3.4) Pregnancy†† 3/33 (9.1) 3/33 (9.1) N/A N/A Symptom §§ Cough 155/180 (86.1) 43/47 (91.5) 54/60 (90.0) 58/73 (79.5) Fever/Chills 153/180 (85.0) 38/47 (80.9) 53/60 (88.3) 62/73 (84.9) Shortness of breath 144/180 (80.0) 40/47 (85.1) 50/60 (83.3) 54/73 (74.0) Myalgia 62/180 (34.4) 20/47 (42.6) 23/60 (38.3) 19/73 (26.0) Diarrhea 48/180 (26.7) 10/47 (21.3) 17/60 (28.3) 21/73 (28.8) Nausea/Vomiting 44/180 (24.4) 12/47 (25.5) 17/60 (28.3) 15/73 (20.5) Sore throat 32/180 (17.8) 8/47 (17.0) 13/60 (21.7) 11/73 (15.1) Headache 29/180 (16.1) 10/47 (21.3) 12/60 (20.0) 7/73 (9.6) Nasal congestion/Rhinorrhea 29/180 (16.1) 8/47 (17.0) 13/60 (21.7) 8/73 (11.0) Chest pain 27/180 (15.0) 9/47 (19.1) 13/60 (21.7) 5/73 (6.8) Abdominal pain 15/180 (8.3) 6/47 (12.8) 6/60 (10.0) 3/73 (4.1) Wheezing 12/180 (6.7) 3/47 (6.4) 2/60 (3.3) 7/73 (9.6) Altered mental status/Confusion 11/180 (6.1) 3/47 (6.4) 2/60 (3.3) 6/73 (8.2) Abbreviations: COVID-NET = Coronavirus Disease 2019–Associated Hospitalization Surveillance Network; N/A = not applicable. * Counties included in COVID-NET surveillance: California (Alameda, Contra Costa, and San Francisco counties); Colorado (Adams, Arapahoe, Denver, Douglas, and Jefferson counties); Connecticut (New Haven and Middlesex counties); Georgia (Clayton, Cobb, DeKalb, Douglas, Fulton, Gwinnett, Newton, and Rockdale counties); Iowa (one county represented); Maryland (Allegany, Anne Arundel, Baltimore, Baltimore City, Calvert, Caroline, Carroll, Cecil, Charles, Dorchester, Frederick, Garrett, Harford, Howard, Kent, Montgomery, Prince George’s, Queen Anne’s, St. Mary’s, Somerset, Talbot, Washington, Wicomico, and Worcester counties); Michigan (Clinton, Eaton, Genesee, Ingham, and Washtenaw counties); Minnesota (Anoka, Carver, Dakota, Hennepin, Ramsey, Scott, and Washington counties); New Mexico (Bernalillo, Chaves, Dona Ana, Grant, Luna, San Juan, and Santa Fe counties); New York (Albany, Columbia, Genesee, Greene, Livingston, Monroe, Montgomery, Ontario, Orleans, Rensselaer, Saratoga, Schenectady, Schoharie, Wayne, and Yates counties); Ohio (Delaware, Fairfield, Franklin, Hocking, Licking, Madison, Morrow, Perry, Pickaway and Union counties); Oregon (Clackamas, Multnomah, and Washington counties); Tennessee (Cheatham, Davidson, Dickson, Robertson, Rutherford, Sumner, Williamson, and Wilson counties); and Utah (Salt Lake County). † COVID-NET included data for one child aged 5–17 years with underlying medical conditions and symptoms at admission; data for this child are not included in this table. This child was reported to have chronic lung disease (asthma). Symptoms included fever, cough, gastrointestinal symptoms, shortness of breath, chest pain, and a sore throat on admission. § Obesity is defined as calculated body mass index (BMI) ≥30 kg/m2, and if BMI is missing, by International Classification of Diseases discharge diagnosis codes. Among 73 patients with obesity, 51 (69.9%) had obesity defined as BMI 30–<40 kg/m2, and 22 (30.1%) had severe obesity defined as BMI ≥40 kg/m2. ¶ Among the 60 patients with chronic metabolic disease, 45 had diabetes mellitus only, 13 had thyroid dysfunction only, and two had diabetes mellitus and thyroid dysfunction. ** Cardiovascular disease excludes hypertension. †† Restricted to women aged 15–49 years. §§ Symptoms were collected through review of admission history and physical exam notes in the medical record and might be determined by subjective or objective findings. In addition to the symptoms in the table, the following less commonly reported symptoms were also noted for adults with information on symptoms (180): hemoptysis/bloody sputum (2.2%), rash (1.1%), conjunctivitis (0.6%), and seizure (0.6%). Discussion During March 1–28, 2020, the overall laboratory-confirmed COVID-19–associated hospitalization rate was 4.6 per 100,000 population; rates increased with age, with the highest rates among adults aged ≥65 years. Approximately 90% of hospitalized patients identified through COVID-NET had one or more underlying conditions, the most common being obesity, hypertension, chronic lung disease, diabetes mellitus, and cardiovascular disease. Using the existing infrastructure of two respiratory virus surveillance platforms, COVID-NET was implemented to produce robust, weekly, age-stratified hospitalization rates using standardized data collection methods. These data are being used, along with data from other surveillance platforms (https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview.html), to monitor COVID-19 disease activity and severity in the United States. During the first month of surveillance, COVID-NET hospitalization rates ranged from 0.1 per 100,000 population in persons aged 5–17 years to 17.2 per 100,000 population in adults aged ≥85 years, whereas cumulative influenza hospitalization rates during the first 4 weeks of each influenza season (epidemiologic weeks 40–43) over the past 5 seasons have ranged from 0.1 in persons aged 5–17 years to 2.2–5.4 in adults aged ≥85 years ( 6 ). COVID-NET rates during this first 4-week period of surveillance are preliminary and should be interpreted with caution; given the rapidly evolving nature of the COVID-19 pandemic, rates are expected to increase as additional cases are identified and as SARS-CoV-2 testing capacity in the United States increases. In the COVID-NET catchment population, approximately 49% of residents are male and 51% of residents are female, whereas 54% of COVID-19-associated hospitalizations occurred in males and 46% occurred in females. These data suggest that males may be disproportionately affected by COVID-19 compared with females. Similarly, in the COVID-NET catchment population, approximately 59% of residents are white, 18% are black, and 14% are Hispanic; however, among 580 hospitalized COVID-19 patients with race/ethnicity data, approximately 45% were white, 33% were black, and 8% were Hispanic, suggesting that black populations might be disproportionately affected by COVID-19. These findings, including the potential impact of both sex and race on COVID-19-associated hospitalization rates, need to be confirmed with additional data. Most of the hospitalized patients had underlying conditions, some of which are recognized to be associated with severe COVID-19 disease, including chronic lung disease, cardiovascular disease, diabetes mellitus ( 5 ). COVID-NET does not collect data on nonhospitalized patients; thus, it was not possible to compare the prevalence of underlying conditions in hospitalized versus nonhospitalized patients. Many of the documented underlying conditions among hospitalized COVID-19 patients are highly prevalent in the United States. According to data from the National Health and Nutrition Examination Survey, hypertension prevalence among U.S. adults is 29% overall, ranging from 7.5%–63% across age groups ( 7 ), and age-adjusted obesity prevalence is 42% (range across age groups = 40%–43%) ( 8 ). Among hospitalized COVID-19 patients, hypertension prevalence was 50% (range across age groups = 18%–73%), and obesity prevalence was 48% (range across age groups = 41%–59%). In addition, the prevalences of several underlying conditions identified through COVID-NET were similar to those for hospitalized influenza patients identified through FluSurv-NET during influenza seasons 2014–15 through 2018–19: 41%–51% of patients had cardiovascular disease (excluding hypertension), 39%–45% had chronic metabolic disease, 33%–40% had obesity, and 29%–31% had chronic lung disease ( 6 ). Data on hypertension are not collected by FluSurv-NET. Among women aged 15–49 years hospitalized with COVID-19 and identified through COVID-NET, 9% were pregnant, which is similar to an estimated 9.9% of the general population of women aged 15–44 years who are pregnant at any given time based on 2010 data. †† Similar to other reports from the United States ( 9 ) and China ( 1 ), these findings indicate that a high proportion of U.S. patients hospitalized with COVID-19 are older and have underlying medical conditions. The findings in this report are subject to at least three limitations. First, hospitalization rates by age and COVID-NET site are preliminary and might change as additional cases are identified from this surveillance period. Second, whereas minimum case data to produce weekly age-stratified hospitalization rates are usually available within 7 days of case identification, availability of detailed clinical data are delayed because of the need for medical chart abstractions. As of March 30, chart abstractions had been conducted for approximately 200 COVID-19 patients; the frequency and distribution of underlying conditions during this time might change as additional data become available. Clinical course and outcomes will be presented once the number of cases with complete medical chart abstractions are sufficient; many patients are still hospitalized at the time of this report. Finally, testing for SARS-CoV-2 among patients identified through COVID-NET is performed at the discretion of treating health care providers, and testing practices and capabilities might vary widely across providers and facilities. As a result, underascertainment of cases in COVID-NET is likely. Additional data on testing practices related to SARS-CoV-2 will be collected in the future to account for underascertainment using described methods ( 10 ). Early data from COVID-NET suggest that COVID-19–associated hospitalizations in the United States are highest among older adults, and nearly 90% of persons hospitalized have one or more underlying medical conditions. These findings underscore the importance of preventive measures (e.g., social distancing, respiratory hygiene, and wearing face coverings in public settings where social distancing measures are difficult to maintain) to protect older adults and persons with underlying medical conditions. Ongoing monitoring of hospitalization rates, clinical characteristics, and outcomes of hospitalized patients will be important to better understand the evolving epidemiology of COVID-19 in the United States and the clinical spectrum of disease, and to help guide planning and prioritization of health care system resources. Summary What is already known about this topic? Population-based rates of laboratory-confirmed coronavirus disease 2019 (COVID-19)–associated hospitalizations are lacking in the United States. What is added by this report? COVID-NET was implemented to produce robust, weekly, age-stratified COVID-19–associated hospitalization rates. Hospitalization rates increase with age and are highest among older adults; the majority of hospitalized patients have underlying conditions. What are the implications for public health practice? Strategies to prevent COVID-19, including social distancing, respiratory hygiene, and face coverings in public settings where social distancing measures are difficult to maintain, are particularly important to protect older adults and those with underlying conditions. Ongoing monitoring of hospitalization rates is critical to understanding the evolving epidemiology of COVID-19 in the United States and to guide planning and prioritization of health care resources.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The spread of alcohol consumption behavior in a large social network.

            Alcohol consumption has important health-related consequences and numerous biological and social determinants. To explore quantitatively whether alcohol consumption behavior spreads from person to person in a large social network of friends, coworkers, siblings, spouses, and neighbors, followed for 32 years. Longitudinal network cohort study. The Framingham Heart Study. 12 067 persons assessed at several time points between 1971 and 2003. Self-reported alcohol consumption (number of drinks per week on average over the past year and number of days drinking within the past week) and social network ties, measured at each time point. Clusters of drinkers and abstainers were present in the network at all time points, and the clusters extended to 3 degrees of separation. These clusters were not only due to selective formation of social ties among drinkers but also seem to reflect interpersonal influence. Changes in the alcohol consumption behavior of a person's social network had a statistically significant effect on that person's subsequent alcohol consumption behavior. The behaviors of immediate neighbors and coworkers were not significantly associated with a person's drinking behavior, but the behavior of relatives and friends was. A nonclinical measure of alcohol consumption was used. Also, it is unclear whether the effects on long-term health are positive or negative, because alcohol has been shown to be both harmful and protective. Finally, not all network ties were observed. Network phenomena seem to influence alcohol consumption behavior. This has implications for clinical and public health interventions and further supports group-level interventions to reduce problematic drinking.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The role of stigma and medical mistrust in the routine health care engagement of black men who have sex with men.

              Objectives: We assessed how health care-related stigma, global medical mistrust, and personal trust in one's health care provider relate to engaging in medical care among Black men who have sex with men (MSM).
                Bookmark

                Author and article information

                Contributors
                kaquinn@mcw.edu
                Journal
                AIDS Behav
                AIDS Behav
                AIDS and Behavior
                Springer US (New York )
                1090-7165
                1573-3254
                25 June 2020
                : 1-4
                Affiliations
                GRID grid.30760.32, ISNI 0000 0001 2111 8460, Center for AIDS Intervention Research (CAIR), , Medical College of Wisconsin, ; Milwaukee, WI USA
                Article
                2954
                10.1007/s10461-020-02954-7
                7316348
                32588259
                c0a504e9-078e-4dfa-89d6-e6b7d768c17e
                © Springer Science+Business Media, LLC, part of Springer Nature 2020

                This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

                History
                Categories
                Notes From The Field

                Infectious disease & Microbiology
                Infectious disease & Microbiology

                Comments

                Comment on this article